Related Experiment Video
Updated: Apr 20, 2026

A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
Diagnosis and management of group B streptococcus in pregnancy
Homa K Ahmadzia1, R Phillips Heine1
1Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Duke University Medical Center, DUMC 3967, Durham, NC 27710, USA.
Insights
Group B Streptococcus (GBS) screening and treatment guidelines have significantly reduced neonatal sepsis in the US. This article reviews GBS clinical management, from screening and diagnosis to current and future peripartum therapies.
Area of Science:
- Obstetrics and Gynecology
- Neonatal Health
- Infectious Diseases
Background:
- Group B Streptococcus (GBS) is a major cause of maternal and neonatal morbidity.
- US Centers for Disease Control and Prevention (CDC) guidelines have been implemented over 30 years.
- These guidelines focus on antepartum screening and intrapartum treatment to prevent GBS transmission.
Purpose of the Study:
- To review the clinical implications of GBS in the peripartum period.
- To highlight current screening, diagnosis, and prophylactic interventions for GBS.
- To discuss potential future therapies for managing GBS.
Main Methods:
- Literature review of GBS management strategies.
- Analysis of the impact of CDC guidelines on neonatal sepsis rates.
- Synthesis of information on clinical management and emerging therapies.
Main Results:
- Significant reductions in early-onset GBS neonatal sepsis observed in the United States.
- Established effectiveness of antepartum screening and intrapartum treatment protocols.
- Identification of areas for continued research and therapeutic development.
Conclusions:
- Current GBS management strategies have proven effective in reducing neonatal morbidity.
- Continued adherence to screening and treatment guidelines is crucial.
- Further research into novel therapies may offer enhanced protection against GBS.
Abstract:
Group B streptococcus (GBS) can cause significant maternal and neonatal morbidity. Over the past 30 years, reductions in early-onset GBS neonatal sepsis in the United States have been attributable to the guidelines from the Centers for Disease Control and Prevention for antepartum screening and treating this organism during labor. This article highlights the clinical implications, screening, diagnosis, prophylactic interventions, and future therapies for mothers with GBS during the peripartum period.
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Bacterial Meningitis I: Introduction
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Development of the Oral Microbiota
Diabetes Mellitus: Type 2 and Gestational

